1Borski RJ.Nongenomic membrane actions of glucocorticoids in vertebrates.Trends Endocrinol Metab,2000,11(10):427-436.
2Chen YZ,Qiu J.Possible genomic consequence of nongenomic action of glucocorticoids in neural cells.News Physiol Sci,2001,16:292-296.
3Karssen AM,Meijer OC,van-der-Sandt IC,et al.Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain.Endocrinology,2001,142(6):2686-2694.
4Farrell RJ,Murphy A,Long A,et al.High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy.Gastroenterology,2000,118(2):279-288.
6Cho YJ,Lee KE.Decreased glucocorticoid binding affinity to glucocorticoid receptor is important in the poor response to steroid therapy of older-aged patients with severe bronchial asthma.Allergy Asthma Proc,2003,24(5):353-358.
7Kofler R,Schmidt S,Kofler A,et al.Resistance to glucocorticoid-induced apoptosis in lymphoblastic leukemia.J Endocrinol,2003,178(1):19-27.
8Schaaf MJ,Cidlowski JA.Molecular mechanisms of glucocorticoid action and resistance.J Steroid Biochem Mol Biol,2002,83(1-5):37-48.
9Yudt MR,Jewell CM,Bienstock RJ,et al.Molecular origins for the dominant negative function of human glucocorticoid receptor beta.Mol Cell Biol,2003,23(12):4319-4330.
10Towers R,Naftali T,Gabay G,et al.High levels of glucocorticoid receptors in patients with active Crohn's disease may predict steroid resistance.Clin Exp Immunol,2005,141(2):357-362.
